Krystal Biotech, Inc.
KRYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $345 | $358 | $162 | $341 |
| Short-Term Investments | $253 | $174 | $217 | $97 |
| Receivables | $105 | $42 | $0 | $0 |
| Inventory | $27 | $7 | $0 | $0 |
| Other Curr. Assets | $13 | $7 | $5 | $4 |
| Total Curr. Assets | $742 | $588 | $384 | $442 |
| Property Plant & Equip (Net) | $161 | $168 | $170 | $120 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $152 | $62 | $5 | $64 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $314 | $230 | $175 | $184 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,056 | $818 | $558 | $626 |
| Liabilities | – | – | – | – |
| Payables | $5 | $2 | $4 | $8 |
| Short-Term Debt | $1 | $1 | $2 | $1 |
| Tax Payable | $4 | $2 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $92 | $27 | $23 | $16 |
| Total Curr. Liab. | $102 | $33 | $29 | $26 |
| LT Debt | $6 | $7 | $7 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $7 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $9 | $8 |
| Total Liabilities | $109 | $40 | $36 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$181 | -$270 | -$281 | -$141 |
| AOCI | -$0 | $1 | -$1 | -$0 |
| Other Equity | $1,127 | $1,048 | $804 | $735 |
| Total Equity | $946 | $779 | $522 | $594 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,056 | $818 | $558 | $626 |
| Net Debt | -$338 | -$350 | -$153 | -$333 |